Scientific Programme
Track Information
 
Track 5: Toxicology

Fundacao Oswaldo Cruz, Brazil


University of Liverpool, UK


Indian Institute of Toxicology Research, India


Institute of Chemical Technology, India


University of California, USA



 Time  Track
March 3, 2010
 (Wednesday)
8:30-12:00 ms, MRC Centre for Drug Safety Science,
Dept. Pharmacology
Track 5-1: Biomarkers in Toxicology
Session Chair:

Dr. Rita Mattos, Senior Researcher,
National School of Public Health, Fundacao Oswaldo Cruz,
Ministry of Health, Brazil.

Session Co-Chair:

Dr. Dominic Willia, MRC Centre for Drug Safety Science,
Dept. Pharmacology & Therapeutics, Sherrington Building,
The University of Liverpool, Liverpool, UK.

8:30-8:35
Session Introduction
8:35-9:00

Dr. Kar Chowdhuri, Scientist F and Deputy Director, Embryotoxicology Lab, Indian Institute of Toxicology Research,
P.O. Box No. 80, Mahatma Gandhi Marg, Lucknow 226 001,
Uttar Pradesh, India.

8:35-9:00

Title: Advances and Strategies in Using Biomarkers in Children Lead Exposure
Dr. Rita Mattos, Senior Researcher,
National School of Public Health, Fundacao Oswaldo Cruz,
Ministry of Health, Brazil.

9:25-9:50

Dr. Maibach  Howard, Dermatology, 
University of California, Sanfransisco, CA, USA.

10:15-10:25
Coffee Break
10:25-10:50

Title: Biomarkers of Drug-Induced Liver Injury
Dr. Dominic Williams
, MRC Centre for Drug Safety Science,
Dept. Pharmacology & Therapeutics, Sherrington Building,
The University of Liverpool, Liverpool, UK.

11:15-11:40

sadha


Title: Biomarkers in Neurotoxicity
Dr. Sadhana Sathaye, Reader in Pharmacy,
Dept. of Pharm. Sci. and Tech.,
Institute of Chemical Technology,
Matunga, Mumbai, India.

11:40-12:00
Panel Discussion


Bio-Acoustic-MEMS in Medicine Laboratory, USA


Synthon BV,
The Netherlands


Research Center for Pharmaceutical Nanotechnology, Iran

March 3, 2010
 (Wednesday)
13:00-18:00
Track 5-2: Toxicogenomics & Metabolomics
Session Chair: Call for Host
Session Co-Chair:

Dr. Utkan Demirci,
Bio-Acoustic-MEMS in Medicine (BAMM)Laboratory,
Center for Bioengineering, Department of Medicine,
Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA.

13:00-13:05 Session Introduction
13:05-13:30

Dr. Utkan Demirci,
Bio-Acoustic-MEMS in Medicine (BAMM)Laboratory,
Center for Bioengineering, Department of Medicine,
Brigham and Women’s Hospital, Harvard Medical School,
Boston, MA, USA.

13:55-14:20

Dr. Sandra van Os, Project Leader Clinical R&D, Synthon BV,
Microweg 22, 6503 GN Nijmegen, The Netherlands.

14:45-16:20 Coffee Break & Poster Session
16:20-16:45

Title: Nonviral Cationic Gene Delivery Nanosystems: Geno compatibility and Toxicogenomics Dilemma
Dr. Y. Omidi, Associate Professor, Faculty of Pharmacy,
Director, Research Center for Pharmaceutical Nanotechnology,
Dean, School of Advanced Biomedical Sciences,
Tabriz University of Medical Sciences, Tabriz, Iran.

17:35-18:00 Panel Discussion


Al-Qassim University,
Saudi Arabia



University of Madras, India


SRM University, India


University of Peradeniya,
Sri Lanka



National Institute for Research in Reproductive Health, India

March 3, 2010
 (Wednesday)
 8:30-12:00
Track 5-3: Environmental Toxicology  
Session Chair: Call for Host

Session Co-Chair:

 

Dr. Sivakumar Gowder, Associate Professor,
Dept. Pharmacology & Biochemistry, Al-Qassim University,
College of Pharmacy, Buraidah, Saudi Arabia.

8:30-8:35 Session Introduction

9:00-9:25

anu

Title: Effect of Antioxidants on PCB Induced Changes in Male Reproduction
Dr. Arunakaran J
, Department of Endocrinology,
Dr. ALM PGIBMS, University of Madras, Chennai, India.

9:25-9:50

Title: Composite Ion Exchange Materials and their Applications to Remove Toxic Metal Ions
Dr. MU. Naushad
, SRM University, NCR Campus,
Modinagar, India.

9:50-10:15

shiva

 

 

Title: Kidney, the Major Organ in the Body to Evaluate Toxic and Transport Properties of Environmental Chemicals
Dr. Sivakumar Gowder
, Associate Professor,
Dept. Pharmacology & Biochemistry, Al-Qassim University,
College of Pharmacy, Buraidah, Saudi Arabia.

10:15-10:25 Coffee Break
10:25-10:50

Title: Impact of Melatonin on PCB Induced Neurotoxicity
Dr. P. Venkataraman. Assistant Professor,
Department of Medical Research,
SRM Medical College Hospital and Research Centre,
SRM University, Kattankulathur - 603 203. India.

10:50-11:15

Title: Attitude and Knowledge of Nonsmokers about Secondhand Smoke and their Opinion towards Cessation of Smoking in Malaysia – Findings from International Tobacco Control (ITC) Survey Malaysia
Dr. Mohamed Shukry Zawahir,
South Asian Clinical Toxicology Research Collaboration,
Faculty of Medicine, University of Peradeniya, Peradeniya,
Sri Lanka.

11:15-11:40

Title: Exposure to Bisphenol A, an Environmental Estrogen on Reproductive Health
Dr. Geeta Vanage
,
National Center for Preclinical Reproductive and Genetic Toxicology, National Institute for Research in Reproductive Health (ICMR),
Street, Parel, Mumbai 400 012, Maharashtra, India.

11:40-12:00 Panel Discussion


Indian Institute of Chemical Technology, India


Centre for Cellular and Molecular Biology, India


Yokohama City University, Japan


Children's Hospital Medical Center, USA


Philip Morris International


Radboud University Nijmegen Medical Center, The Netherlands

March 3, 2010
 (Wednesday)
 13:00-18:00
Track 5-4: Molecular Epidemiology  

Session Chair:

 

murthy

Dr. U. S. N Murthy, Director Grade Scientist/Scientist G,
Head Biology Division,
Indian Institute of Chemical Technology (CSIR),
Ministry of Science and Technology Govt India,
Tarnaka, Hyderabad, India.

Session Co-Chair:

 

Dr. M.V Jagannadham,
Scientist, Centre for Cellular and Molecular Biology,
Tarnaka, Hyderabad -500 007, India.

13:00-13:05 Session Introduction
13:30-13:55

Dr. Yoshihiro Ishikawa, Dean, Graduate School of Medicine,
Professor and President, Cardiovascular Research Institute,
Yokohama City University, Graduate School of Medicine, Jap

13:55-14:20

Prof. Michael V. Miles, Clinical Pediatrics and Neurology,
Div. of Pathology & Laboratory Medicine,
Children's Hospital Medical Center, 3333 Burnet Ave.,
Cincinnati, OH 45229, USA.

14:20-14:45

litch

Title: Cigarette Smoke Inhalation Study for Lung Tumorigenicity in A/J Mice
Dr. Rosemarie B. Lichtner,
Philip Morris Research Laboratories GmbH, Germany.

14:45-16:20 Coffee Break & Poster Session
16:20-16:45

Prof. Thamar Stollman, Department of Surgery,
Radboud University Nijmegen Medical Center, Nijmegen,
The Netherlands.

16:45-17:10

 

murthy

Title: Artificial Intelligence : A Magic Bullet for Epidemiological Studies of Vector Borne Diseases
Dr. U.S.N Murthy, Director Grade Scientist/Scientist G,
Head Biology Division,
Indian Institute of Chemical Technology (CSIR),
Ministry of Science and Technology Govt India,
Tarnaka, Hyderabad, India.

17:10-17:35

jagna

 

Title: The Proteome of the Outer Membrane Vesicles of an Antarctic Bacterium Pseudomonas Syringae
Dr. M.V Jagannadham
,
Scientist, Centre for Cellular and Molecular Biology,
Tarnaka, Hyderabad, India.

17:35-18:00 Panel Discussion
 
Track 6: PK/PD and Drug Discovery


Shandong University School Of  Medicine, China


Aizant Drug Research Solutions, India


Piramal Life Sciences, India


Meerut Institute of Engineering and Technology, India


Florida A & M University, USA


Indian Institute of Technology, India





 Time  Track
March 3, 2010
 (Wednesday)
8:30-12:00
Track 6-1: Anticancer, Antiviral Drug Development
Session Chair:

Dr. Harish Joshi, Laboratory of Drug Discovery,
Design and Research, Department of Cell Biology,
Suite 455 Whitehead Bld., WBRB, 615 Michael Street,
Atlanta, GA-30322, USA.

Session Co-Chair:

Dr. Guo Rui Chen, Institute of Clinical Pharmacology,
Qilu Hospital of Shandong University, Jinan, Shandong, China.

8:30-8:35 Session Introduction

8:35-9:00

tha

Title: Challenges in siRNA/shRNA Delivery and Development of RNAi Therapeutics for Cancer
Dr. Tathagata Dutta
, Deputy Director,
Formulation Developm Tathagata Duttaent and Drug Discovery Research,
Aizant Drug Research Solutions,
Hyderabad, India.

9:00-9:25

Title: Pharmacokinetics, Metabolism and Tissue Distribution of Norcantharidin in Human Body, Studied by HPLC-MS/MS and Isotope-labeled Methods
Dr. Guo Rui Chen
, Institute of Clinical Pharmacology,
Qilu Hospital of Shandong University, Jinan, Shandong, China.

9:25-9:50

Title: Recent Advances in Anticancer Drug Discovery: Multiple Target Approach to Tackle Tough Tumors
Dr. Sanjay Kumar,
Group Leader,
Department of Medicinal Chemistry, Piramal Life Sciences,
Nirlon Complex, Off Western Express Highway, Goregaon (E),
Mumbai 400 063, India.

9:50-10:15

Title: Quantitative Structure-Activity Relationship Studies on Anti-Hepatitis Viral Agents
Dr. S.P.Gupta
, Departemt of Pharmaceutical Technology,
Meerut Institute of Engineering and Technology, Meerut, India.

10:15-10:25 Coffee Break
10:25-10:50

Title: Targetted therapy for Treatment of Lung Cancer
Dr. Mandip Singh Sachdeva, Professor and section Leader, Pharmaceutics, Florida A & M University, College of Pharmacy,
Editor in Chief, CRC Critical Reviews in Therapeutic Drug Carrier Systems, Tallahassee, Florida, USA.

10:50-11:15

Title: Hopeful Trip from Herbs to Humans
Dr. Harish Joshi
, Laboratory of Drug Discovery,
Design and Research, Department of Cell Biology,
Suite 455 Whitehead Bld., WBRB, 615 Michael Street,
Atlanta, GA-30322, USA.

11:15-11:40

Title: Nano-drug Deliverysystem Particularly for Anti-cancer Drug
Prof P.Pramanik
, nano-materials laboratory,
Chemistry Department, Indian Institute of Technology,
Kharagpur, 721302 , India.

11:40-12:00 Panel Discussion

University at Buffalo, USA


Ludwig-Maximilians University, Germany


University of Alberta, Canada


Indian Institute of Chemical Technology, India


Guru Jambheshwar University of Science and Technology, India
March 3, 2010
 (Wednesday)
13:00-18:00
Track 6-2: Molecular Drug Targets and Fragment based Drug Design
Session Chair:

Dr. Wojciech Krzyzanski, Department of Pharmaceutical Sciences, University at Buffalo, Buffalo, NY 14260, USA.

Session Co-Chair: Dr. Nazar Soeiro
13:00-13:05 Session Introduction
13:05-13:30

Title: Assessment of Exposure to Carcinogens: Correlation of Surrogate Biomarkers with Adducts in Target Tissues
Dr. Franky Richter
, Walther Straub Institute,
Department of Toxicology, Ludwig-Maximilians University, Germany.

13:55-14:20

wogi

Title: Minimal Effective Concentration and Efficacy of Epoetins
Dr. Wojciech Krzyzanski
, Department of Pharmaceutical Sciences, University at Buffalo, Buffalo, NY 14260, USA.

14:20-14:45

Dr. Fakhreddin Jamali,
Faculty of Pharmacy & Pharmaceutical Sciences,
University of Alberta, Edmonton, Alberta, Canada.

14:45-16:20 Coffee Break & Poster Session
16:20-16:45

Dr. Nazar Soeiro

16:45-17:10

Title: Biophotonics: Application towards Modern Drug Discovery
Dr. Srinivas kantevari, Sr. Scientist,
Organic Chemistry Division-II,
Indian Institute of Chemical Technology,
Hyderabad, India.

17:10-17:35

Title: Molecular Drug Targets for Development of Antidepressant Drugs
Dr. Dinesh Dhingra
, Assistant Professor,
Pharmacology Division,
Department of Pharmaceutical Sciences,
Guru Jambheshwar University of Science and Technology,
Hisar-125001-Haryana, India.

17:35-18:00 Panel Discussion


Kuwait University, Kuwait


Panjab University, India


Monash Institute of Pharmaceutical Sciences, Australia


AstraZeneca R&D M闤ndal, Sweden

University of British Columbia, Canada


Rashtrasant Tukadoji Maharaj Nagpur University, India

March 3, 2010
 (Wednesday)
8:30-12:00
Track 6-3: Improving ADME/DMPK Profile
Session Chair:

Dr. Aly Nada, Assoc.Professor & Chairman,
Department of Pharmaceutics, Faculty of Pharmacy,
Kuwait University, POB 24923 Safat, 13110 Kuwait.

Session Co-Chair:

bhoop

Prof. Bhupinder Singh Bhoop,
Pharmaceutics & Pharmacokinetics,
Univ Inst Pharm Sci (UGC Center of Adv Studies),
Dean (Alumni Relations), Panjab University, Chandigarh, India.

8:30-8:35 Session Introduction
8:35-9:00

Dr. Jian Li
Facility for Anti-infective Drug Development and Innovation,
Drug Delivery, Disposition and Dynamics,
Monash Institute of Pharmaceutical Sciences,
Monash University, Australia.

9:00-9:25

Dr. Hong Wan,
Lead Generation DMPK and Physical Chemistry,
AstraZeneca R&D M闤ndal, Sweden.

9:25-9:50

Title: Stability and Rat Skin Permeation of Vitamin E and Vitamin E Acetate in Cosmetic Preparations
Dr. Aly Nada
, Assoc.Professor & Chairman,
Department of Pharmaceutics, Faculty of Pharmacy,
Kuwait University, POB 24923 Safat, 13110 Kuwait.

9:50-10:15

Dr. William Jia, Department of Surgery, Faculty of Medicine,
University of British Columbia, Brain Research Centre, Canada.

10:15-10:25 Coffee Break

10:25-10:50

bhoop

Title: Enhancing Oral Bioavailability of Drugs using Self-Emulsifying Drug Delivery Systems
Prof. Bhupinder Singh Bhoop
,
Pharmaceutics & Pharmacokinetics,
Univ Inst Pharm Sci (UGC Center of Adv Studies),
Dean (Alumni Relations), Panjab University, Chandigarh, India.

10:50-11:15

Title: Pharmacokinetic Significance of Diabetes-induced Changes in CYP3A Activity
Prof. S. N. Umathe, Head of Pharmacology Division,
Department of Pharmaceutical Sciences,
Rashtrasant Tukadoji Maharaj Nagpur University,
Mahatma Jyotiba Fuley Shaikshanik Parisar,
Amravati Road , Nagpur, India.

11:40-12:00 Panel Discussion


Mayo Clinic School of Medicine, USA


Institut Sup廨ieur de Biotechnologies de Sfax, Tunisie


Vaagdevi college of Pharmacy, India

March 3, 2010
 (Wednesday)
 13:00-18:00
Track 6-4: PK/PD and Bioanalysis Outsourcing Alliance

Session Chair:

 

Prof. Debabrata Mukhopadhyay,
Department of Biochemistry and Molecular Biology,
Mayo Clinic School of Medicine, Guggenheim 1401A,
200 First Street Southwest, Rochester, MN 55905, USA.

Session Co-Chair:

Dr. Anupama Ramkumar, Director, Arkus CTSS, Ahmedabad, India.

13:00-13:05 Session Introduction
13:30-13:55

Title: More than a Co-receptor: New Perspectives of Neuropilin-1 Function in Endothelium and Tumor Cells
Prof. Debabrata Mukhopadhyay
,
Department of Biochemistry and Molecular Biology,
Mayo Clinic School of Medicine, Guggenheim 1401A,
200 First Street Southwest, Rochester, MN 55905, USA.

13:55-14:20

Dr. Sofiane Bezzine
Institut Sup廨ieur de Biotechnologies de Sfax,
Route de Soukra km 4, Sfax 3038, Tunisie.

14:20-14:45

Dr. S.Tamilvanan

14:45-16:20 Coffee Break & Poster Session
16:20-16:45

Title: Bioequivalence Studies for Generics in Patients - Trials or Tribulations?
Dr. Anupama Ramkumar
,
Director, Arkus CTSS, Ahmedabad, India.

16:45-17:10

Title: Local Antibiotic Delivery Systems for the Treatment of Osteomyelitis, the Use of Fibrin Clot as a Carrier- an In Vitro and In Vivo Pharmacokinetic Study
Dr. Stefanos Tsourvakas, Orthopaedic Department,
General Hospital of Trikala, Greece.

17:10-17:35

Title: Pharmacokinetic Study of Hair Dye Poisoning: A Study of 50 cases
Dr. M. Nagulu, Department of Clinical Pharmacy Services,
M.G.M Hospital, Vaagdevi college of Pharmacy, Warangal, India.

17:35-18:00 Panel Discussion


Central Drug Research Institute, India


Sun Pharma, India



Jahaharlal Nehru Technological University, India


Satara College of Pharmacy, India

March 3, 2010
 (Wednesday)
 13:00-18:00
Track 6-5: Road Map to Drug Discovery and Develoment
Session Chair:

Dr. Girish kumar jain,
Head, Division of Pharmacokinetics & Metabolism,
Central Drug Research Institute, Lucknow-226001, India.

Session Co-Chair:

Dr. Sanjay Mandhane, Pharmacology Division,
Sun Pharma Advanced Research Company Limited,
Atladara, Tandalja Road, Vadodara, Gujarat 390 020, India.

13:00-13:05 Session Introduction
13:05-13:30

Title: Is Natural Product Domain a Good Hunting Hub in the Navigation of Drug Like and Drug Molecules?
Dr. A. Jayashree, Scientist, Jahaharlal Nehru Technological University, Hyderabad, India.

13:55-14:20

Title: Materials and Methods for Innovation-Are We Ready for Drug Discovery?
Dr. Sanjay Mandhane
, Pharmacology Division,
Sun Pharma Advanced Research Company Limited,
Atladara, Tandalja Road, Vadodara, Gujarat 390 020, India.

14:45-16:20 Coffee Break & Poster Session
16:20-16:45

Title: Therapeutic Alternatives from Venoms and Toxins : Drug Challenges of the Future
Prof. Shivaji P.Gawade,
Professor in Pharmacology and Principal,
Satara College of Pharmacy, Plot 1539,
New Additional MIDC, Behind Spicer India Ltd,
Degaon, Satara, M.S., India.

16:45-17:10

Title: Human Membrane Guanylate Cyclases: Understanding the Structural Basis of Receptor-Ligand Interactions and Approaches to Drug Design
Prof. Paul Roesch, Research Center for Bio-Macromolecules,
U. of Bayreuth 95440 Bayreuth, Germany.

17:35-18:00 Panel Discussion
 
Track 7: Bioavailability


All India Institute of Medical Sciences, India


Govt. College of Pharmacy, India



 

 Time  Track
March 3, 2010
 (Wednesday)
 8:30-12:00
Track 7-1: Influence of Disease on Bioavailability
Session Chair: Call for Host
Session Co-Chair:

Dr. Thirumurthy velpandian,
Associate Professor & In-Charge,
Department of Ocular Pharmacology & Pharmacy,
Dr.Rajendra Prasad Centre for Ophthalmic Sciences,
All India Institute of Medical Sciences, New Delhi, India.

8:30-8:35 Session Introduction
8:35-9:00

Title: Liver Diseses Affecting Bioavailability
Dr. Dibya Sundar Panda
, Institute of Pharmacy and Technology, Salipur-754202, Cuttack, India.

9:25-9:50

Title: Pros and Cons of Ocular bio-availability of Drugs
Dr. Thirumurthy velpandian
,
Associate Professor & In-Charge,
Department of Ocular Pharmacology & Pharmacy,
Dr.Rajendra Prasad Centre for Ophthalmic Sciences,
All India Institute of Medical Sciences, New Delhi, India.

10:15-10:25 Coffee Break
10:25-10:50

Dr. Motte Laurence, Universit Paris, Nanomaterials group,
CSPBAT Laboratory, France.

10:50-11:15

Title: Are Bioavailability Studies Warranted in Specific Disease States?
Dr. S.B. Bhise, Principal, Govt. College of Pharmacy,
Karad, India.

11:40-12:00 Panel Discussion


Andhra University, India


Novartis, USA


University Children's Hospital Basel, Switzerland


University of Kentucky School of Medicine, USA


Huashan hospital of Fudan University, China


Jagiellonian University


Royal College of Surgeons in Ireland, Ireland

March 3, 2010
 (Wednesday)
13:00-18:00
Track 7-2: Factors Influencing Bioavailability and Bioequivalence
Session Chair:

Prof. T. Satyanarayana,
Principal, College of Pharmaceutical Sciences,
Andhra University, Visakhapatnam, India.

Session Co-Chair:

 

Dr. Tycho Heimbach,
Novartis Institutes for BioMedical Research,
DMPK - Translational Sciences (TS), USEH, 436/3253,
One Health Plaza, East Hanover, NJ 07936-1080, USA.

13:00-13:05 Session Introduction
13:05-13:30

Title: Immunomodulation by Biologic Intravenous Immunoglobulins IVIG: Immune Thrombocytopenia ITP as a Model for the last 30 Years
Dr. Paul Imbach
, University Children's Hospital Basel UKBB, Basel, Switzerland

13:30-13:55

michel

Title: The Bioavailability of Heparin-binding Molecules on Vascular Walls is Regulated by Heparan Sulfate and Flow Rate
Dr. Michael Fannon,
University of Kentucky School of Medicine,
Lexingto

13:55-14:20

Dr. Peinan Sun, The Department of Clinical Pharmacology,
Huashan hospital of Fudan University, Shanghai, China.

14:20-14:45

 

vijay

Title: Factors Influencing Bioavailability and Bioequivalence
Prof. Vijaya Ratna, AU College of Pharmaceutical Sciences,
Andhra University, Visakhapatnam, India.

14:45-16:20 Coffee Break & Poster Session

16:20-16:45

 

Title: Roles of Oral Drug Absorption, Bioavailability and Exposure Prediction in Drug Development
Dr. Tycho Heimbach,
Novartis Institutes for BioMedical Research,
DMPK - Translational Sciences (TS), USEH, 436/3253,
One Health Plaza, East Hanover, NJ 07936-1080, USA.

16:45-17:10

Title: Combining Population-based Mechanistic Modeling of Oral Absorption and Parameter Estimation Algorithms to Obtain Reliable Predictions of Bioavailability
Prof. Sebastian Polak, Jagiellonian Univ, Krakow,
Poland and Simcyp, Poland.

17:10-17:35

cox

Title: Aspirin Resistance: The Role of Poor Bioavailability of Enteric Coated Aspirin
Dr. Dermot Cox, Molecular and Cellular Therapeutics,
Royal College of Surgeons in Ireland,
123 St. Stephens Green, Dublin 2, Ireland.

17:35-18:00 Panel Discussion

KLE University, India


University of Texas at Austin, USA


Saudi Food and Drug Authority, Saudi Arabia


University of Ljubljana, Slovenia

March 3, 2010
 (Wednesday)
 8:30-12:00
Track 7-3: The Role of Intestinal Metabolism on Bioavailability

Session Chair:

bhasava

Prof. Basavaraj K. Nanjwade, Department of Pharmaceutics,
JN Medical college, KLE University, Belgaum- 590010,
Karnataka, India.

Session Co-Chair: Call for Co-Host
8:30-8:35 Session Introduction
8:35-9:00

Title: Challenges in Establishing Bioequivalence of Complex Modified Release Dosage Forms
Dr. Salomon Stavchansky
, Division of Pharmaceutics,
College of Pharmacy, University of Texas at Austin, Austin, Texas, USA.

9:25-9:50

Dr. Abdullah Al-Mohizea,
Director of Product Evaluation and Standard Setting Department, Drug Sector, Saudi Food and Drug Authority, Riyadh, Saudi Arabia.

9:50-10:15

Title: The Importance of Intestinal Wall Metabolism – the Case of Raloxifene
Dr. Trontelj Jurij
, Dept. Biopharmacy and Pharmacokinetics,
Faculty of Pharmacy, University of Ljubljana Askerceva 7, Ljubljana, Slovenia.

10:15-10:25 Coffee Break

10:25-10:50

Title: Enhancing Drug Bioavailability by Overcoming Intestinal Metabolism
Prof. Basavaraj K. Nanjwade, Department of Pharmaceutics,
JN Medical college, KLE University, Belgaum- 590010,
Karnataka, India.

10:50-11:15

Title: Enhancement of Bioavailability of Aceclofenac Using Solid Dispersion Technique
Dr. Sharma V. K, D.J. College of Pharmacy, Modinagar, 201204, UP, India.

11:40-12:00 Panel Discussion


Cetero Research, USA


Panacea Biotec Ltd., India


Y.B. Chavan College of Pharmacy, India


Panjab University, India


Dibrugarh University, India


M. L. Sukhadia University, India


Dr H S Gour University, India

 

March 3, 2010
 (Wednesday)
  13:00-18:00
Track 7-4: In Vitro Methods to Determine Bioavailability & In Vitro-In Vivo Correlations
Session Chair:

Dr. Sam Raney,
Associate Director, Pre-Clinical Dermatology,
Cetero Research, Adjunct Professor of Pharmaceutical Sciences at North Dakota State University, USA.

Session Co-Chair:

shiva

 

Dr. Shivanand Puthli, Drug Delivery Division,
Panacea Biotec Ltd., Navi-Mumbai, Maharashtra, India.

13:00-13:05 Session Introduction

13:05-13:30

sam

Title: Assessing BA/BE of Topical Formulations In Vitro:
In Vitro – In Vivo Correlation Provides a Practical Surrogate to Clinical BE Studies
Dr. Sam Raney
, Associate Director, Pre-Clinical Dermatology,
Cetero Research, Adjunct Professor of Pharmaceutical Sciences at North Dakota State University, USA.

13:30-13:55

shiva

Title: Understanding the Significance of In-vitro/ In-vivo Correlation in Pharmacokinetic Predictions
Dr. Shivanand Puthli
, Drug Delivery Division,
Panacea Biotec Ltd., Navi-Mumbai, Maharashtra, India.

13:55-14:20

vijay

Title: In Vitro Methods to Determine Bioavailability & IVIVC of Oral Dosage Forms and Drug Delivery Systems
Dr. Vijay D. Wagh, Associate Professor In Pharmaceutics,
Y.B. Chavan College of Pharmacy, Aurangabad.
and
Editor In Chief, Indian Journal of Pharmaceutics,
Serial Publications, Daria Ganj, New Delhi, India.

14:20-14:45

bhoop

Title: Endeavoring Biowaivers Using IVIVC: Shifting Paradigms
Prof. Bhupinder Singh Bhoop,
Pharmaceutics & Pharmacokinetics,
Univ Inst Pharm Sci (UGC Center of Adv Studies),
Dean (Alumni Relations), Panjab University, Chandigarh, India.

14:45-16:20 Coffee Break & Poster Session
16:20-16:45

Title: Transdermal Bioavailability of Trazodone Hydrochloride: Invitro-Invivo Correlation
Dr. Malay K. Das
, Division of Pharmaceutics,
Department of Pharmaceutical Sciences, Dibrugarh University,
Dibrugarh 786004, India.

16:45-17:10

Title: Effect of Test Parameters on In-vitro Method to Determine Bioavailability of Dosage Forms
Dr. Abhishek kumar Jain, Research Scholar and Lecturer,
Department of Pharmaceutical Science,
M. L. Sukhadia University, Udaipur, Rajasthan, India.

17:10-17:35

Dr. Avijeet Jain,
Research Scholar, Natural Product Research Laboratory,
Dept of Pharmaceutical Sciences, Dr H S Gour University,
Sagar, MP, India.

17:35-18:00 Panel Discussion
 
Participants List
(Academia)
University of Notre Dame, USA

Faculty of Medicine Siriraj Mahidol University, Thailand

Nova Southeastern University, USA

The Australian National University Medical School, University of Canberra, Australia

University of Hyderabad, India

Panjab University, Chandigarh, India

Institute of Biotechnology and Antibiotics, Warsaw, Poland

Texas Tech School of Pharmacy, USA

University of Petra, Jordan

Jadavpur University, India

University of British Columbia, Canada

Canadian Society for Pharmaceutical Sciences, Canada

National University of Singapore, Singapore

King Saud University, Saudi Arabia

Widener University, USA

Stanford University School of Medicine, USA

University at Buffalo, State University of New York, USA

School of Biological Sciences, University of Edinburgh, UK

Chungnam National University, Korea

Harvard Medical School, USA

Polish Academy of Sciences, Poland

University of Trieste, Italy

College of Pharmaceutical Sciences, MAHE, India

Medical School, University of Athens, Greece

Universiade Federal da Bahia, Instituto de Ci瘽cias da Saude, Brazil

University of Region of Cariri - URCA, Brazil

Tabriz University of Medical Sciences, Iran

Johns Hopkins University, USA

Creighton University Medical Center and University of Nebraska Medical Center, USA

University of Pisa, Italy

University of Notre Dame, USA

Faculty of Medicine Siriraj Mahidol University, Thailand

Nova Southeastern University, USA

The Australian National University Medical School, University of Canberra, Australia

University of Hyderabad, India

Panjab University, Chandigarh, India

Institute of Biotechnology and Antibiotics, Warsaw, Poland

Texas Tech School of Pharmacy, USA

University of Petra, Jordan

Jadavpur University, India

University of British Columbia, Canada

Canadian Society for Pharmaceutical Sciences, Canada

National University of Singapore, Singapore

King Saud University, Saudi Arabia

Widener University, USA

Stanford University School of Medicine, USA

University at Buffalo, State University of New York, USA

School of Biological Sciences, University of Edinburgh, UK

Chungnam National University, Korea

Harvard Medical School, USA

Polish Academy of Sciences, Poland

University of Trieste, Italy

College of Pharmaceutical Sciences, MAHE, India

Medical School, University of Athens, Greece

Universiade Federal da Bahia, Instituto de Ci瘽cias da Saude, Brazil

University of Region of Cariri - URCA, Brazil

Tabriz University of Medical Sciences, Iran

Johns Hopkins University, USA

Creighton University Medical Center and University of Nebraska Medical Center, USA

University of Pisa, Italy


Participants List
(Business)
US Pharmacopeia, USA

Food and Drug Administration, USA

University Hospital Zurich, Switzerland

B. V. Patel Perd Centre, India

Guy's Hospital, UK

H繫pital Saint-Antoine, Paris

A. Manzoni Hospital, Italy

Kazusa DNA Research Institute, Japan

Pharmaceutics Int., Inc., USA

Agilent Technologies, USA

Central Drug Research Institute, India

EMF Consulting, France

Hopital Cochin, Paris

Boys Town National Research Hospital, Omaha, USA

Aurobindo Pharma Ltd., India

US Pharmacopeia, USA

Food and Drug Administration, USA

University Hospital Zurich, Switzerland

B. V. Patel Perd Centre, India

Guy's Hospital, UK

H繫pital Saint-Antoine, Paris

A. Manzoni Hospital, Italy

Kazusa DNA Research Institute, Japan

Pharmaceutics Int., Inc., USA

Agilent Technologies, USA

Central Drug Research Institute, India

EMF Consulting, France

Hopital Cochin, Paris

Boys Town National Research Hospital, Omaha, USA

Aurobindo Pharma Ltd., India